ydqcau, I note when you refer to the head and neck trial, that you tend to favour this indication , if data continues to be favourable, as the indication most likely to have the potential to be first to market as opposed to the lung cancer trial,is this because you believe head and neck has a more favourable chance of receiving a designation such as accelerated approval or break through approval opposed to lung cancer.
ydqcau, I note when you refer to the head and neck trial, that...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.015(3.66%) |
Mkt cap ! $505.2M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 44.0¢ | 39.5¢ | $3.455M | 8.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 81510 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
43.0¢ |
Change
0.015 ( 4.44 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 43.8¢ | 39.5¢ | 1912918 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| IMM (ASX) Chart |